Mitotherapeutix

Business Data, Corporate Office and Headquarter Address

About

Mitotherapeutix is Drug Discovery in United States that focus on liver disorders business. Founded in 2014. They cover business area such as developer, molecule-base drug, cancer, degenerative liver disorder, disease, modifying, metabolic pathway, help, physician, critical condition, kidney.

Business Type

Drug Discovery

Country

United States

Founded

2014
( 10 years old in 2024 )

Company Focus

Liver Disorders

Website

-

Corporate Office and Headquarter Office address:

400 Farmington Avenue
Farmington, CT 06032
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

developermolecule-base drugcancerdegenerative liver disorderdiseasemodifyingmetabolic pathwayhelpphysiciancritical conditionkidney

* We use standard office opening hours in near Mitotherapeutix's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Mitotherapeutix Frequently Asked Questions

What or who is Mitotherapeutix?

Mitotherapeutix is Drug Discovery business from United States that founded in 2014 (10 years old in 2024), Mitotherapeutix business is focusing on Liver Disorders.

Where is Mitotherapeutix headquarter and corporate office address?

Mitotherapeutix headquarter office and corporate office address is located in 400 Farmington Avenue Farmington, CT 06032 United States.

Where is Mitotherapeutix country origins?

Mitotherapeutix was founded in United States.

What is Liver Disorders business focus on?

In 2024, Mitotherapeutix is currently focus on liver disorders sector.

Liver Disorders Business Interest from Google Trend

Above is snippet of Google Trends for "liver disorders" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Mitotherapeutix, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.